Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts

References

• Abaasa, A. M., Todd, J., Ekoru, K., Kalyango, J. N., Levin, J., Odeke, E., & Karamagi, C. A. S. (2008). Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: The experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Services Research, 8(1), 241. doi:10.1186/1472-6963-8-241
   PubMed Web of Science ®Google Scholar
• Abioye, A. I., Isanaka, S., Liu, E., Mwiru, R. S., Noor, R. A., Spiegelman, D., … Fawzi, W. (2015). Gender differences in diet and nutrition among adults initiating antiretroviral therapy in Dar es Salaam, Tanzania. AIDS Care, 27(6), 706–715.
   PubMed Web of Science ®Google Scholar
• Addo, M. M., & Altfeld, M. (2014). Sex-based differences in HIV type 1 pathogenesis. Journal of Infectious Diseases, 209(Suppl. 3), S86–S92.
   PubMed Web of Science ®Google Scholar
• Agaba, P. A., Digin, E., Makai, R., Apena, L., Agbaji, O. O., Idoko, J. A., … Kanki, P. (2011). Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. The Journal of Infection in Developing Countries, 5(5), 377–382.
   Google Scholar
• Alibhai, A., Kipp, W., Saunders, L. D., Senthilselvan, A., Kaler, A., Houston, S., & Alibhai, P. (2010). Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. International Journal of Women's Health, 2, 45–52.
   PubMedGoogle Scholar
• Amornkul, P. N., Karita, E., Kamali, A., Rida, W. N., Sanders, E. J., Lakhi, S. … Fast, P. E. (2013). Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. AIDS, 27(17), 2775–2786.
   PubMed Web of Science ®Google Scholar
• Barchielli, A., Acciai, S., Lazzeri, V., & Buiatti, E. (1997). Survival after AIDS diagnosis in Tuscany (Italy), 1985–1992. European Journal of Epidemiology, 13(2), 125–132.
   PubMed Web of Science ®Google Scholar
• Bastard, M., Soulinphumy, K., Phimmasone, P., Saadani, A. H., Ciaffi, L., Communier, A., … Etard, J.-F. (2013). Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic. BMC Infectious Diseases, 13, 27–35.
   PubMed Web of Science ®Google Scholar
• Biber, C. L., Jaker, M. A., Kloser, P., Auerbach, S. B., & Rhoads, G. G. (1999). A study of sex differences in presentation for care of HIV. AIDS Patient Care and STDs, 13(2), 103–110.
   PubMed Web of Science ®Google Scholar
• Borgdorff, M. W., Barongo, L. R., Klokke, A. H., Newell, J. N., Senkoro, K. P., Velema, J. P., & Gabone, R. M. (1995). HIV-1 incidence and HIV-1 associated mortality in a cohort of urban factory workers in Tanzania. Genitourin Med, 71(4), 212–215.
   PubMedGoogle Scholar
• Braga, P., Cardoso, M. R., & Segurado, A. C. (2007). Gender differences in survival in an HIV/AIDS cohort from Sao Paulo, Brazil. AIDS Patient Care and STDs, 21(5), 321–328.
   PubMed Web of Science ®Google Scholar
• Bucciardini, R., D'Ettorre, G., Baroncelli, S., Ceccarelli, G., Parruti, G., Weimer, L. E., … Floridia, M. (2012). Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors. International Journal of STD & AIDS, 23(7), 459–463.
   PubMed Web of Science ®Google Scholar
• Bush, C. E., Donovan, R. M., Markowitz, N., Baxa, D., Kvale, P., & Saravolatz, L. D. (1996). Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia. Journal of clinical microbiology, 34(4), 970–972.
   PubMed Web of Science ®Google Scholar
• Byakwaga, H., Petoumenos, K., Ananworanich, J., Zhang, F., Boyd, M., Sirisanthana, T., … Emery, S. (2013). Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific Region results from the TREAT Asia HIV Observational Database. Journal of the International Association of Providers of AIDS Care (JIAPAC), 12(4), 270–277.
   PubMedGoogle Scholar
• Casseb, J., Komninakis, S., Abdalla, L., Brigido, L. F., Rodrigues, R., Araujo, F., … da Silva Duarte, A. J. (2002). HIV disease progression: Is the Brazilian variant subtype B’ (GWGR motif) less pathogenic than US/European subtype B (GPGR)? International Journal of Infectious Diseases, 6(3), 164–169.
   PubMedGoogle Scholar
• Castilho, J. L., Melekhin, V. V., & Sterling, T. R. (2014). Sex Differences in HIV Outcomes in the Highly Active Antiretroviral Therapy Era: A Systematic Review. AIDS Research and Human Retroviruses, 30(5), 446–456.
   PubMed Web of Science ®Google Scholar
• CDC. (2013). Differences between HIV-infected men and women in antiretroviral therapy outcomes – Six African countries, 2004–2012. CDC Morbidity and Mortality Weekly Report (MMWR), 62(47), 946–952.
   Google Scholar
• Cescon, A. M., Palmer, A. K., Chan, K., Margolese, S., Raboud, J., Milan, D., … Loutfy, M. R. (2013). Women with a history of injection drug use at greatest risk for poorer clinical outcomes in a cohort of HIV-positive individuals in Canada: A CANOC study. Canadian Journal of Infectious Diseases and Medical Microbiology, 22, 22B.
   Google Scholar
• Chaisson, R. E., Keruly, J. C., & Moore, R. D. (1995). Race, sex, drug use, and progression of human immunodeficiency virus disease. New England Journal of Medicine, 333(12), 751–756.
   PubMed Web of Science ®Google Scholar
• Chang, H.-G. H., Morse, D. L., Noonan, C., Coles, B., Mikl, J., Rosen, A., … Smith, P. F. (1993). Survival and mortality patterns of an acquired immunodeficiency syndrome (AIDS) cohort in New York State. American Journal of Epidemiology, 138(5), 341–349.
   PubMed Web of Science ®Google Scholar
• Chen, S. C. C., Yu, J. K. L., Harries, A. D., Bong, C. N., Kolola-Dzimadzi, R., Tok, T. S., … Wang, J.-D. (2008). Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Tropical Medicine and International Health, 13(4), 513–519.
   PubMed Web of Science ®Google Scholar
• Ciglenecki, I., Glynn, J. R., Mwinga, A., Ngwira, B., Zumla, A., Fine, P. E., & Nunn, A. (2007). Population differences in death rates in HIV-positive patients with tuberculosis. Int J Tuberc Lung Dis, 11(10), 1121–1128.
   PubMed Web of Science ®Google Scholar
• Coetzee, D., Hildebrand, K., Boulle, A., Maartens, G., Louis, F., Labatala, V., … Goemaere, E. (2004). Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS, 18(6), 887–895.
   PubMed Web of Science ®Google Scholar
• Collazos, J., Asensi, V., & Carton, J. A. (2007). Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS, 21(7), 835–843.
   PubMed Web of Science ®Google Scholar
• Cornell, M., Myer, L., Kaplan, R., Bekker, L. G., & Wood, R. (2009). The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Tropical Medicine & International Health, 14(7), 722–731.
   PubMed Web of Science ®Google Scholar
• Cornell, M., Schomaker, M., Garone, D. B., Giddy, J., Hoffmann, C. J., Lessells, R., … Myer, L. (2012). Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: A multicentre cohort study. PLoS Medicine, 9(9), e1001304.
   PubMed Web of Science ®Google Scholar
• Cozzi Lepri, A., Pezzotti, P., Dorrucci, M., Phillips, A. N., & Rezza, G. (1994). HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study. BMJ, 309(6968), 1537–1542.
   PubMed Web of Science ®Google Scholar
• Crabtree-Ramirez, B., Villasis-Keever, A., Galindo-Fraga, A., Del Rio, C., & Sierra-Madero, J. (2010). Effectiveness of highly active antiretroviral therapy (HAART) among HIV-infected patients in Mexico. AIDS Research and Human Retroviruses, 26(4), 373–378.
   PubMed Web of Science ®Google Scholar
• Currier, J., Averitt Bridge, D., Hagins, D., Zorrilla, C. D., Feinberg, J., Ryan, R., … GRACE (Gender, Race, And Clinical Experience) Study Group. (2010). Sex-based outcomes of darunavir-ritonavir therapy: A single-group trial. Annals of Internal Medicine, 153(6), 349–357.
   PubMed Web of Science ®Google Scholar
• De Brito, A., Komninakis, S. C. V., Novoa, P., De Oliveira, R. M., Fonseca, L. A. M., Duarte, A. J. S., & Casseb, J. (2006). Women infected with HIV type 1 Brazilian variant, subtype B (B'-GWGR Motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR Motif). Clinical Infectious Diseases, 43(11), 1476–1481.
   PubMed Web of Science ®Google Scholar
• DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177–188.
   PubMedGoogle Scholar
• DeSilva, M. B., Merry, S. P., Fischer, P. R., Rohrer, J. E., Isichei, C. O., & Cha, S. S. (2009). Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria. AIDS Care, 21(1), 70–77.
   PubMed Web of Science ®Google Scholar
• Diamond, C., Taylor, T. H., & Anton-Culver, H. (2002). Characteristics and survival of patients with non-Hodgkin's lymphoma with and without acquired immunodeficiency syndrome. Hematological Oncology, 20(4), 177–187.
   PubMed Web of Science ®Google Scholar
• Dias, S. S., Andreozzi, V., Martins, M. O., & Torgal, J. (2009). Predictors of mortality in HIV-associated hospitalizations in Portugal: A hierarchical survival model. BMC Health Services Research, 9, 125–134.
   PubMed Web of Science ®Google Scholar
• Dou, Z., Xu, J., Jiao, J. H., Ma, Y., Durako, S., Yu, L., … Zhang, F. (2009). Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006–2008. PLoS One, 6(8), e22707.
   Web of Science ®Google Scholar
• Druyts, E., Dybul, M., Kanters, S., Nachega, J., Birungi, J., Ford, N., … Mills, E. J. (2013). Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: A systematic review and meta-analysis. AIDS, 27(3), 417–425.
   PubMed Web of Science ®Google Scholar
• Druyts, E. F., Rachlis, B. S., Lima, V. D., Harvard, S. S., Zhang, W., Brandson, E. K., … Hogg, R. S. (2009). Mortality is influenced by locality in a major HIV/AIDS epidemic. HIV Medicine, 10(5), 274–281.
   PubMed Web of Science ®Google Scholar
• Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629–634.
   PubMed Web of Science ®Google Scholar
• Etard, J.-F., Ndiaye, I., Thierry-Mieg, M., Gueye, N. F. N., Gueye, P. M., Laniece, I., … Delaporte, E. (2006). Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: A 7-year cohort study. AIDS, 20(8), 1181–1189.
   PubMed Web of Science ®Google Scholar
• Farzadegan, H., Hoover, D. R., Astemborski, J., Lyles, C. M., Margolick, J. B., Markham, R. B., … Vlahov, D. (1998). Sex differences in HIV-1 viral load and progression to AIDS. The Lancet, 352(9139), 1510–1514.
   PubMed Web of Science ®Google Scholar
• Fawzi, W. W., Msamanga, G. I., Spiegelman, D., Wei, R., Kapiga, S., Villamor, E., … Hunter, D. J. (2004). A randomized trial of multivitamin supplements and HIV disease progression and mortality. New England Journal of Medicine, 351(1), 23–32.
   PubMed Web of Science ®Google Scholar
• Fonseca, L. A., Reingold, A. L., Casseb, J. R., Brigido, L. F., & Duarte, A. J. (1999). AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in Sao Paulo, Brazil. International Journal of Epidemiology, 28(6), 1156–1160.
   PubMed Web of Science ®Google Scholar
• Fordyce, E. J., Singh, T. P., Nash, D., Gallagher, B., & Forlenza, S. (2002). Survival rates in NYC in the era of combination ART. Journal of Acquired Immune Deficiency Syndromes, 30(1), 111–118.
   PubMed Web of Science ®Google Scholar
• Fregonese, F., Collins, I. J., Jourdain, G., LeCoeur, S., Cressey, T. R., Ngo-Giang-Houng, N., … Lallemant, M. (2012). Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand. Journal of Acquired Immune Deficiency Syndromes, 60(1), 91–98.
   PubMed Web of Science ®Google Scholar
• Geng, E. H., Glidden, D. V., Emenyonu, N., Musinguzi, N., Bwana, M. B., Neilands, T. B., … Martin, J. N. (2010). Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Tropical Medicine & International Health, 15(Suppl. 1), 63–69.
   PubMed Web of Science ®Google Scholar
• Ghosh, C., Jongsthapongpanth, A., & Bagchi-Sen, S. (2009). Survival of an AIDS cohort in Thailand (2000–2005). AIDS Care, 21(12), 1568–1577.
   PubMed Web of Science ®Google Scholar
• Goujard, C., Girault, I., Rouzioux, C., Lecuroux, C., Deveau, C., Chaix, M. L., … Sinet, M. (2012). HIV-1 control after transient antiretroviral treatment initiated in primary infection: Role of patient characteristics and effect of therapy. Antiviral Therapy, 17(6), 1001–1009.
   PubMed Web of Science ®Google Scholar
• Grabar, S., Kousignian, I., Sobel, A., Le Bras, P., Gasnault, J., Enel, P., … Costagliola, D. (2004). Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS, 18(15), 2029–2038.
   PubMed Web of Science ®Google Scholar
• Graham, S. M., Mugo, P., Gichuru, E., Thiong'o, A., Macharia, M., Okuku, H. S., … Sanders, E. J. (2012). Adherence to antiretroviral therapy and clinical outcomes among young adults reporting high-risk sexual behavior, including men who have sex with men, in coastal Kenya. AIDS and Behavior, 17(4), 1255–1265.
   Web of Science ®Google Scholar
• Greig, J., Casas, E. C., O'Brien, D. P., Mills, E. J., & Ford, N. (2012). Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries. AIDS, 26, 31–37.
   Google Scholar
• van Griensven, J., & Thai, S. (2011). Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 105(12), 694–703.
   PubMed Web of Science ®Google Scholar
• Grigoryan, A., Hall, H. I., Durant, T., & Wei, X. (2009). Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996–2004. PLoS One, 4(2), e4445.
   PubMed Web of Science ®Google Scholar
• Grinsztejn, B., Smeaton, L., Barnett, R., Klingman, K., Hakim, J., Flanigan, T., … Currier, J. (2009). Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4+ T-cell count. Antiviral Therapy, 16(7), 1057–1062.
   Web of Science ®Google Scholar
• Guiguet, M., Kendjo, E., Carcelain, G., Abgrall, S., Mary-Krause, M., Tattevin, P., … Duval, X. (2009). CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts ≥200 cells/mm3. Antiviral Therapy, 14(3), 451–457.
   PubMed Web of Science ®Google Scholar
• Hall, H. I., McDavid, K., Ling, Q., & Sloggett, A. (2006). Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001. Annals of Epidemiology, 16(11), 824–833.
   PubMed Web of Science ®Google Scholar
• Hanna, D. B., Buchacz, K., Gebo, K. A., Hessol, N. A., Horberg, M. A., Jacobson, L. P., … Mendes, A. (2013). Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001–2009. Clinical Infectious Diseases, 56(8), 1174–1182.
   PubMed Web of Science ®Google Scholar
• Hawkins, C., Chalamilla, G., Okuma, J., Spiegelman, D., Hertzmark, E., Aris, E., … Fawzi, W. (2011). Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS, 25(9), 1189–1197.
   PubMed Web of Science ®Google Scholar
• De La Hera, M. G., Ferreros, I., Del Amo, J., De Olalla, P. G., Hoyos, S. P., Muga, R., … Hernández-Aguado, I. (2004). Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting dug users from 1986 to 2001. Journal of Epidemiology and Community Health, 58(11), 944–950.
   PubMed Web of Science ®Google Scholar
• Hernando, V., Perez-Cachafeiro, S., Lewden, C., Gonzalez, J., Segura, F., Oteo, J. A., … Amo, J. D. (2012). All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. Journal of Hepatology, 57(4), 743–751.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., & Deeks, J. J. (2008). Selecting studies and collecting data. In Higgins, J. P. & Green, S. (Eds.), Cochrane handbook for systematic reviews of interventions (Vol. 5, pp. 16–26). Oxford: The Cochrane Collaboration.
   Google Scholar
• Hill, S., & Kavookjian, J. (2012). Motivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: A systematic review of the literature. AIDS Care, 24(5), 583–592.
   PubMed Web of Science ®Google Scholar
• Hodder, S., Arasteh, K., De Wet, J., Gathe, J., Gold, J., Kumar, P., … Boven, K (2012). Effect of gender and race on the week 48 findings in treatment-naive, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE. HIV Medicine, 13(7), 406–415.
   PubMed Web of Science ®Google Scholar
• Hodder, S., Jayaweera, D., Mrus, J., Ryan, R., & Witek, J. (2012). Efficacy and safety outcomes among treatment-experienced women and men treated with etravirine in gender, race and clinical experience. AIDS Research and Human Retroviruses, 28(6), 544–551.
   PubMed Web of Science ®Google Scholar
• Hoffman, R. M., Umeh, O. C., Garris, C., Givens, N., & Currier, J. S. (2007). Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women. HIV Clinical Trials, 8(6), 371–380.
   PubMed Web of Science ®Google Scholar
• Hogg, R. S., Heath, K. V., Strathdee, S. A., Montaner, J. S. G., O'shaughnessy, M. V., & Schlechter, M. T. (2001). Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA, 286(20), 2568–2577.
   PubMed Web of Science ®Google Scholar
• Hulgan, T., Shepherd, B. E., Raffanti, S. P., Fusco, J., Beckerman, R., Barkanic, G., … Sterling, T. R. (2007). Absolute count and percentage of CD4+ lymphocytes are independent precistors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy. Journal of Infectious Diseases, 195, 425–431.
   PubMed Web of Science ®Google Scholar
• Jarrin, I., Geskus, R., Bhaskaran, K., Prins, M., Perez-Hoyos, S., Muga, R., … Amo, J. D. (2008). Gender differences in HIV progression to AIDS and death in industrialized countries: Slower disease progression following HIV seroconversion in women. American Journal of Epidemiology, 168(5), 532–540.
   PubMed Web of Science ®Google Scholar
• Johannessen, A., Naman, E., Ngowi, B. J., Sandvik, L., Matee, M. I., Aglen, H. E., … Bruun, J. N. (2008). Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infectious Diseases, 8(1), 52–61.
   PubMed Web of Science ®Google Scholar
• Junghans, C., Ledergerber, B., Chan, P., Weber, R., & Egger, M. (1999). Sex differences in HIV-1 viral load and progression to AIDS. Swiss HIV cohort study. The Lancet, 353(9152), 589; author reply 589–581.
   PubMed Web of Science ®Google Scholar
• Kanters, S., Nansubuga, M., Mwehire, D., Odiit, M., Kasirye, M., Musoke, W., … Mills, E. J. (2013). Increased mortality among HIV-positive men on antiretroviral therapy: Survival differences between sexes explained by late initiation in Uganda. HIV AIDS (Auckl), 5, 111–119.
   PubMedGoogle Scholar
• Karcher, H., Omondi, A., Odera, J., Kunz, A., & Harms, G. (2007). Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Tropical Medicine & International Health, 12(5), 687–694.
   PubMed Web of Science ®Google Scholar
• Keruly, J. C., & Moore, R. D. (2007). Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006. Clinical Infectious Diseases, 45(10), 1369–1374.
   PubMed Web of Science ®Google Scholar
• Kicinski, M. (2013). Publication Bias in Recent Meta-Analyses. PloS One, 8(11), e81823.
   PubMed Web of Science ®Google Scholar
• Kipp, W., Alibhai, A., Saunders, L. D., Senthilselvan, A., Kaler, A., Konde-Lule, J., … Rubaale, T. (2010). Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care, 22(3), 271–278.
   PubMed Web of Science ®Google Scholar
• Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., … Moore, R. D. (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine, 360(18), 1815–1826.
   PubMed Web of Science ®Google Scholar
• Ko, N. Y., Lai, Y. Y., Liu, H. Y., Ko, W. C., Chang, C. M., Lee, N. Y., … Lee, H. C. (2014). Gender differences in HIV manifestations at presentation to care and continuity of care among HIV-infected persons in Taiwan. AIDS Care, 23(10), 1254–1263.
   Web of Science ®Google Scholar
• Kumarasamy, N., Venkatesh, K. K., Cecelia, A. J., Devaleenol, B., Saghayam, S., Yepthomi, T., … Mayer, K. H. (2008). Gender-based differences in treatment and outcome among HIV patients in South India. Journal of Women's Health, 17(9), 1471–1475.
   PubMed Web of Science ®Google Scholar
• Kuyper, L. M., Wood, E., Montaner, J. S., Yip, B., O'Connell, J. M., & Hogg, R. S. (2004). Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes, 37(4), 1470–1476.
   PubMed Web of Science ®Google Scholar
• Lemp, G. F., Hirozawa, A. M., Cohen, J. B., Derish, P. A., McKinney, K. C., & Hernandez, S. R. (1992). Survival for women and men with AIDS. Journal of Infectious Diseases, 166(1), 74–79.
   PubMed Web of Science ®Google Scholar
• Lima, V. D., Hogg, R. S., Harrigan, P. R., Moore, D., Yip, B., Wood, E., & Montaner, J. S. G. (2007). Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. Aids, 21(6), 685–692.
   PubMed Web of Science ®Google Scholar
• Lyles, C. M., Dorrucci, M., Vlahov, D., Pezzotti, P., Angarano, G., Sinicco, A., … Rezza, G. (1999). Longitudinal human immunodeficiency virus type 1 load in the Italian seroconversion study: Correlates and temporal trends of virus load. Journal of Infectious Diseases, 180(4), 1018–1024.
   PubMed Web of Science ®Google Scholar
• Maman, D., Pujades-Rodriguez, M., Subtil, F., Pinoges, L., McGuire, M., Ecochard, R., … Etard, J.-F. (2012). Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa. PLoS One, 7(2), e31078.
   PubMed Web of Science ®Google Scholar
• Marmot, M., Friel, S., Bell, R., Houweling, T. A., & Taylor, S. (2008). Closing the gap in a generation: Health equity through action on the social determinants of health. The Lancet, 372(9650), 1661–1669.
   PubMed Web of Science ®Google Scholar
• Maskew, M., Brennan, A. T., Westreich, D., McNamara, L., MacPhail, A. P., & Fox, M. P. (2013). Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients. Journal of Women's Health, 22(2), 113–120.
   PubMed Web of Science ®Google Scholar
• Mave, V., Gahunia, M., Frontini, M., Clark, R., & Mushatt, D. (2011). Gender differences in HIV drug resistance mutations and virological outcome. Journal of Women's Health, 20(1), 117–122.
   PubMed Web of Science ®Google Scholar
• McMahon, J. H., Elliott, J. H., Bertagnolio, S., Kubiak, R., & Jordan, M. R. (2013). Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review. Bulletin of the World Health Organization, 91(5), 377–385E.
   PubMed Web of Science ®Google Scholar
• Mills, E. J., Bakanda, C., Birungi, J., Chan, K., Ford, N., Cooper, C. L., … Hoggm, R. S. (2011). Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: A cohort analysis from Uganda. Annals of Internal Medicine, 155(4), 209–217.
   PubMed Web of Science ®Google Scholar
• Miro, J. M., Manzardo, C., Mussini, C., Johnson, M., Monforte, A. D. A., Antinori, A., … Sabin, C. (2011). Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis. PloS One, 6(10), e26009.
   PubMed Web of Science ®Google Scholar
• Mocroft, A., Gill, M., Davidson, W., & Phillips, A. (2000). Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? JAIDS Journal of Acquired Immune Deficiency Syndromes, 24(5), 475–482.
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.
   PubMed Web of Science ®Google Scholar
• Moore, A. L., Kirk, O., Johnson, A. M., Katlama, C., Blaxhult, A., Dietrich, M., … Phillips, A. N. (2003). Virologic, immunologic, and clinical response to highly active antiretroviral therapy: The gender issue revisited. Journal of Acquired Immune Deficiency Syndromes, 32(4), 452–461.
   PubMed Web of Science ®Google Scholar
• Moore, A. L., Mocroft, A., Madge, S., Devereux, H., Wilson, D., Phillips, A. N., … Johnson, M. (2001). Gender differences in virologic response to treatment in an HIV-positive population: A cohort study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 26(2), 159–163.
   PubMed Web of Science ®Google Scholar
• Moore, A. L., Sabin, C. A., Johnson, M. A., & Phillips, A. N. (2002). Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 29(2), 197–202.
   PubMed Web of Science ®Google Scholar
• Mosha, F., Muchunguzi, V., Matee, M., Sangeda, R. Z., Vercauteren, J., Nsubuga, P., … Vandamme, A.-M. (2013). Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania. BMC Public Health, 13, 38–44.
   PubMed Web of Science ®Google Scholar
• Mujugira, A., Wester, C. W., Kim, S., Bussmann, H., & Gaolathe, T. (2009). Patients with advanced HIV type 1 infection initiating antiretroviral therapy in Botswana: treatment response and mortality. AIDS Research and Human Retroviruses, 25(2), 127–133.
   PubMed Web of Science ®Google Scholar
• Mutevedzi, P. C., Lessells, R. J., Rodger, A. J., & Newell, M.-L. (2011). Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults. PloS One, 6(7), e21795.
   PubMed Web of Science ®Google Scholar
• Mzileni, M. O., Longo-Mbenza, B., & Chephe, T. J. (2008). Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital. Polskie Archiwum Medycyny Wewnetrznej, 118(10), 548–554.
   PubMedGoogle Scholar
• Nachega, J. B., Hislop, M., Dowdy, D. W., Lo, M., Omer, S. B., Regensberg, L., … Maartens, G. (2006). Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(1), 78–84.
   PubMed Web of Science ®Google Scholar
• Nakagawa, F., May, M., & Phillips, A. (2013). Life expectancy living with HIV: recent estimates and future implications. Current Opinion in Infectious Diseases, 26(1), 17–25.
   PubMed Web of Science ®Google Scholar
• Napravnik, S., Poole, C., Thomas, J. C., & Eron, J. J., Jr. (2002). Gender difference in HIV RNA levels: A meta-analysis of published studies. JAIDS Journal of Acquired Immune Deficiency Syndromes, 31(1), 11–19.
   PubMed Web of Science ®Google Scholar
• Nicastri, E., Angeletti, C., Palmisano, L., Sarmati, L., Chiesi, A., Geraci, A., … Vella, S. (2005). Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS, 19(6), 577–583.
   PubMed Web of Science ®Google Scholar
• O'Connell, J. M., Braitstein, P., Hogg, R. S., Yip, B., Craib, K. J., O'Shaughnessy, M. V, … Burdge, D. R. (2003). Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme. Antiviral Therapy, 8(6), 569–576.
   PubMed Web of Science ®Google Scholar
• von Overbeck, J., Egger, M., Smith, G. D., Schoep, M., Ledergerber, B., Furrer, H., … Malinverni, R. (1994). Survival in HIV infection: do sex and category of transmission matter? Swiss HIV cohort study. AIDS, 8(9), 1307–1313.
   PubMed Web of Science ®Google Scholar
• Palmer, T. M., Peters, J. L., Sutton, A. J., & Moreno, S. G. (2008). Contour-enhanced funnel plots for meta-analysis. Stata Journal, 8(2), 242 . Retrieved from http://repec.org/usug2009/palmer_presentation.pdf
   Web of Science ®Google Scholar
• Patterson, K., Napravnik, S., Eron, J., Keruly, J., & Moore, R. (2007). Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy. HIV Medicine, 8(6), 406–410.
   PubMed Web of Science ®Google Scholar
• Pence, B. W., Ostermann, J., Kumar, V., Whetten, K., Thielman, N., & Mugavero, M. J. (2008). The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 47(2), 194–201.
   PubMed Web of Science ®Google Scholar
• Perez-Hoyos, S., Rodriguez-Arenas, M. A., De La Hera, M. G., Iribarren, J. A., Moreno, S., Vaciana, P., … Amo, J. D. (2007). Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort. Journal of Women's Health, 16(7), 1052–1061.
   PubMed Web of Science ®Google Scholar
• Perez-Molina, J. A., Mora Rillo, M., Suarez-Lozano, I., Casado-Osorio, J. L., Teira Cobo, R., Rivas Gonzalez, P., … González-García, J. (2012). Response to combined antiretroviral therapy according to gender and origin in a cohort of naive HIV-infected patients: GESIDA-5808 study. HIV Clinical Trials, 13(3), 131–141.
   PubMed Web of Science ®Google Scholar
• Peterson, I., Togun, O., De Silva, T., Oko, F., Rowland-Jones, S., Jaye, A., & Peterson, K. (2011). Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia. AIDS, 25(17), 2167–2175.
   PubMed Web of Science ®Google Scholar
• Pezzotti, P., Galai, N., Vlahov, D., Rezza, G., Lyles, C. M., & Astemborski, J. (1999). Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: Results from the ALIVE and ISS studies. AIDS link to intravenous experiences. Italian seroconversion study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(3), 275–282.
   PubMedGoogle Scholar
• Poole, W. K., Fulkerson, W., Lou, Y., Kvale, P., Hopewell, P. C., Hirschtick, R., … Markowitz, N. (1996). Overall and cause-specific mortality in a cohort of homo-/bisexual men, injecting drug users, and female partners of HIV-infected men. Pulmonary Complications of Human Immunodeficiency Virus Infection Study Group. AIDS, 10(11), 1257–1264.
   PubMed Web of Science ®Google Scholar
• Poundstone, K. E., Chaisson, R. E., & Moore, R. D. (2001). Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS, 15(9), 1115–1123.
   PubMed Web of Science ®Google Scholar
• Prins, M., Robertson, J. R., Brettle, R. P., Aguado, I. H., Broers, B., Boufassa, F., … van den Hoek, A. (1999). Do gender differences in CD4 cell counts matter? AIDS, 13(17), 2361–2364.
   PubMed Web of Science ®Google Scholar
• Raboud, J., Blitz, S., Walmsley, S., Thompson, C., Rourke, S. B., Loutfy, M. R. & Ontario HIV Treatment Network Cohort Study Team. (2010). Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naive HIV-infected individuals initiating combination antiretroviral therapy. HIV Clinical Trials, 11(6), 340–350.
   PubMed Web of Science ®Google Scholar
• Rosenberg, M. S. (2005). The file-drawer problem revisited: A general weighted method for calculating fail-safe numbers in meta-analysis. Evolution, 59(2), 464–468.
   PubMed Web of Science ®Google Scholar
• Routman, J. S., Willig, J. H., Westfall, A. O., Abroms, S. R., Varshney, M., Adusumilli, S., … Mugavero, M. J. (2011). Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care. Clinical Infectious Diseases, 50(4), 574–584.
   Web of Science ®Google Scholar
• Sabine, C., & Collaboration, A. T. C. (2005). AIDS events among individuals initiating HAART: Do some patients experience a greater benefit from HAART than others? AIDS, 19(17), 1995–2000.
   PubMed Web of Science ®Google Scholar
• Safren, S. A., O'Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012). Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 80(3), 266–277.
   Web of Science ®Google Scholar
• Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., … Gange, S. J. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PloS One, 8(12), e81355.
   PubMed Web of Science ®Google Scholar
• Sangsari, S., Milloy, M., Ibrahim, A., Kerr, T., Zhang, R., Montaner, J., … Wood, E. (2012). Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: An observational study. BMC Infectious Diseases, 12(1), 22–27.
   PubMed Web of Science ®Google Scholar
• Santoro-Lopes, G., Harrison, L. H., Moulton, L. H., Lima, L. A., de Pinho, A. M., Hofer, C., … Schechter, M. (1998). Gender and survival after AIDS in Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19(4), 403–407.
   PubMedGoogle Scholar
• Saunders, P., Goodman, A., Smith, C., Marshall, N., O'Connor, J., Lampe, F., … Sullivan, A. K. (2013). Gender differences in outcomes to first-line treatment in the era of modern antiretroviral therapy (ART). HIV Medicine, 14, 6–9.
   PubMed Web of Science ®Google Scholar
• Scherrer, A. U., Ledergerber, B., von Wyl, V., Böni, J., Yerly, S., Klimkait, T., … Swiss HIV Cohort Study. (2011). Improved virological outcome in white patients infected with HIV-1 non-B subtypes compared to subtype B. Clinical Infectious Diseases, 53(11), 1143–1152.
   Google Scholar
• Sieleunou, I., Souleymanou, M., Schönenberger, A. M., Menten, J., & Boelaert, M. (2009). Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Tropical Medicine & International Health, 14(1), 36–43.
   PubMed Web of Science ®Google Scholar
• Soon, G., Min, M., Struble, K. A., Chan-Tack, K. M., Hammerstrom, T., Qi, K., … Birnkrant, D. B. (2012). Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000–2008). AIDS Patient Care and STDs, 26(8), 444–453.
   PubMed Web of Science ®Google Scholar
• Srasuebkul, P., Lim, P. L., Lee, M. P., Kumarasamy, N., Zhou, J., Sirisanthana, T., … Law, M. G. (2009). Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clinical Infectious Diseases, 48(7), 940–950.
   PubMed Web of Science ®Google Scholar
• Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology, 25(9), 603–605.
   Google Scholar
• Sterling, T. R., Chaisson, R. E., & Moore, R. D. (2001). HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS, 15(17), 2251–2257.
   PubMed Web of Science ®Google Scholar
• Taniguchi, T., Grubb, J. R., Nurutdinova, D., Önen, N. F., Shacham, E., Donovan, M., … Onen, N. F. (2012). Efavirenz outperforms boosted atazanavir among treatment-naive HIV-1-infected persons in routine clinical care. Journal of the International Association of Providers of AIDS Care (JIAPAC), 12(2), 138–141.
   PubMedGoogle Scholar
• Thiébaut, R., Morlat, P., Jacqmin-Gadda, H., Neau, D., Mercié, P., Dabis, F., … Chêne, G. (2000). Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. AIDS, 14(8), 971–978.
   PubMed Web of Science ®Google Scholar
• Thorsteinsson, K., Ladelund, S., Jensen-Fangel, S., Larsen, M. V., Johansen, I. S., Katzenstein, T. L., … Lebech, A.-M. (2012). Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: A nationwide cohort study. Scandinavian Journal of Infectious Diseases, 44(10), 766–775.
   PubMed Web of Science ®Google Scholar
• Torti, C., Lapadula, G., Maggiolo, F., Casari, S., Suter, F., Minoli, L., … Carosi, G. (2007). Predictors of AIDS-defining events among advanced naive patients after HAART. HIV Clinical Trials, 8(3), 112–120.
   PubMed Web of Science ®Google Scholar
• Tran, D. A., Ngo, A. D., Shakeshaft, A., Wilson, D. P., Doran, C., & Zhang, L. (2013). Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: Findings from 13 outpatient clinics. PLoS One, 8(9), 44–66.
   Google Scholar
• Vervloet, M., Linn, A. J., van Weert, J. C., De Bakker, D. H., Bouvy, M. L., & Van Dijk, L. (2012). The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. Journal of the American Medical Informatics Association, 19(5), 696–704.
   PubMed Web of Science ®Google Scholar
• Wandeler, G., Keiser, O., Pfeiffer, K., Pestilli, S., Fritz, C., Labhardt, N. D., … Ehmer, J. (2012). Outcomes of antiretroviral treatment programs in rural Southern Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59(2), e9–e16.
   PubMed Web of Science ®Google Scholar
• Webber, M. P., Schoenbaum, E. E., Gourevitch, M. N., Bouno, D., & Klein, R. S. (1999). A prospective study of HIV disease progression in female and male drug users. AIDS, 13(2), 257–262.
   PubMed Web of Science ®Google Scholar
• Weigel, R., Estill, J., Egger, M., Harries, A. D., Makombe, S., Tweya, H., … Keiser, O. (1999). Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS, 26(3), 365–373.
   Web of Science ®Google Scholar
• WHO. (2013). WHO definitions of clinical, immunological and virological failure for the decision to switch ART regimens. In Harries Anthony, & Hirnschall, Gottfried (Eds.), WHO_CG_table_7.15 (p. 134). Geneva: WHO.
   Google Scholar
• Wingard, D. L. (1984). The sex differential in morbidity, mortality, and lifestyle. Annual Review of Public Health, 5(1), 433–458.
   PubMed Web of Science ®Google Scholar
• Wolbers, M., Battegay, M., Hirschel, B., Furrer, H., Cavassini, M., Hasse, B., … Yerly, S. (2007). CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antiviral Therapy, 12(6), 889–897.
   PubMed Web of Science ®Google Scholar
• Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., & Montaner, J. S. (2003). Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS, 17(5), 711–720.
   PubMed Web of Science ®Google Scholar
• WorldBank. (2014). Country classification table. Retrieved from http://data.worldbank.org/about/country-and-lending-groups
   Google Scholar
• Zangerle, R., Reibnegger, G., & Klein, J.-P. (1995). Survival differences in Austrian patients with the acquired immunodeficiency syndrome. European Journal of Epidemiology, 11(5), 519–526.
   PubMed Web of Science ®Google Scholar
• Zhang, J., & Yu, K. (1998). What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA, 280(19), 1690–1691.
   PubMed Web of Science ®Google Scholar